67
Views
6
CrossRef citations to date
0
Altmetric
Review

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia

Pages 997-1005 | Published online: 02 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ken Kishida, Tohru Funahashi & Iichiro Shimomura. (2013) Effects of pitavastatin on HDL metabolism. Clinical Lipidology 8:1, pages 55-68.
Read now

Articles from other publishers (5)

Asita Wongprikorn, Chonlaphat Sukasem, Apichaya Puangpetch, Pawin Numthavej, Ammarin Thakkinstian & Sasisopin Kiertiburanakul. (2016) Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study. PLOS ONE 11:6, pages e0157531.
Crossref
Zdenko Časar. 2016. Synthesis of Heterocycles in Contemporary Medicinal Chemistry. Synthesis of Heterocycles in Contemporary Medicinal Chemistry 113 185 .
Kevin C. Maki, Harold E. Bays & Mary R. Dicklin. (2012) Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence. Journal of Clinical Lipidology 6:5, pages 413-426.
Crossref
Roger E. Morgan, Stuart E. Campbell, Christine Y. Yu, Craig A. Sponseller & Heather A. Muster. (2012) Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects. Journal of Cardiovascular Pharmacology 60:1, pages 42-48.
Crossref
R A Wilke, L B Ramsey, S G Johnson, W D Maxwell, H L McLeod, D Voora, R M Krauss, D M Roden, Q Feng, R M Cooper-DeHoff, L Gong, T E Klein, M Wadelius & M Niemi. (2012) The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy. Clinical Pharmacology & Therapeutics 92:1, pages 112-117.
Crossref